Explore 3 Stock Ideas & Industry Insights Download Free Report

International Display Advertising Inc

Company price
0.0021 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
594
Market Cap
0.23M

Momentum Score

…

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.05
High
52 Week Price Range
0.00
Low
0.05
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

International Display Advertising Inc (OTCQB: IRME) is an OTCQB-listed company; public disclosures are limited and the firm's core operations, revenue sources and strategy are not clearly documented. The company's long-term prospects may depend on establishing a verifiable business model, producing audited financial statements and executing growth initiatives that clarify its market position.
Material risks include low trading liquidity and wide spreads typical of microcap OTC listings, lack of audited financials and operating history, execution and financing risk that could lead to severe dilution, and broader regulatory and compliance exposure.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.02M
Revenue Per Share
-
Gross Profit TTM
0.08M
Debt / Equity
-
ROE
-5349.30%
Net Debt
0.03M
ROCE
660.20%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.90M -4.91M -4.73M -3.72M -0.75M
Net income -1.90M -4.91M -4.73M -3.72M -0.75M
Selling general administrative 1.15M 2.71M 2.74M 2.18M 0.32M
Reconciled depreciation 0.02M 0.02M 0.01M 0.01M 0.00M
Ebit - - -4.76M -3.67M -0.73M
Ebitda - - -4.72M -3.71M -0.74M
Operating income -1.94M -4.91M -4.76M -3.67M -0.73M
Interest expense - - 0.01M 0.01M 0.01M
Interest income - 0.02M - - -
Net interest income -0.00M 0.02M -0.01M -0.01M -0.01M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 1.94M 4.91M 4.76M 3.67M 0.73M
Total other income expense net 0.05M -0.02M 0.04M -0.04M -0.01M
Net income from continuing ops -1.90M -4.91M -4.73M -3.72M -0.75M
Net income applicable to common shares - - -4.73M -3.72M -0.75M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.25M 1.00M 3.29M 2.94M 2.09M
Other current assets - - - - 0.19M
Total liab 0.55M 0.63M 0.70M 0.57M 0.69M
Total stockholder equity -0.29M 0.36M 2.59M 2.37M 1.40M
Other current liab - - 0.11M 0.03M 0.02M
Common stock - - 0.07M 0.06M 0.05M
Capital stock 0.07M 0.07M 0.07M 0.06M 0.05M
Retained earnings -16.74M -14.84M -9.93M -5.20M -1.48M
Other assets - - 0.01M 0.03M -
Cash 0.13M 0.77M 3.00M 2.81M 1.87M
Total current liabilities 0.55M 0.47M 0.66M 0.40M 0.52M
Net debt 0.03M - - - -
Short long term debt 0.16M - 0.16M - -
Other stockholder equity - - - - 0.02M
Property plant equipment - - 0.23M 0.03M 0.01M
Total current assets 0.20M 0.85M 3.06M 2.88M 2.08M
Net tangible assets - - 2.59M 2.37M 1.40M
Net receivables - - 0.04M 0.07M 0.03M
Long term debt - 0.16M - 0.18M 0.17M
Accounts payable 0.06M 0.06M 0.07M 0.06M 0.03M
Non currrent assets other 0.01M 0.01M 0.01M - -
Non current assets total 0.05M 0.15M 0.24M 0.06M 0.01M
Capital lease obligations 0.00M 0.04M 0.11M - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.00M 0.00M -0.06M -0.06M 0.00M
Change to liabilities - - 0.04M -0.08M 0.32M
Total cashflows from investing activities - - -0.06M -0.06M -0.06M
Net borrowings -0.01M 0.00M - - -
Total cash from financing activities 0.75M 1.00M 3.62M 3.49M 2.04M
Change to operating activities - - - - 0.02M
Net income -1.90M -4.91M -4.73M -3.72M -0.75M
Change in cash -0.64M -2.23M 0.19M 0.95M 1.63M
Begin period cash flow 0.77M 3.00M 2.81M 1.87M 0.23M
End period cash flow 0.13M 0.77M 3.00M 2.81M 1.87M
Total cash from operating activities -1.39M -3.23M -3.38M -2.48M -0.40M
Issuance of capital stock 0.76M 1.00M 3.62M 3.49M 2.04M
Depreciation 0.02M 0.02M 0.01M 0.01M 0.00M
Other cashflows from investing activities - - -0.01M -0.03M -0.03M
Change to account receivables 0.01M -0.03M 0.01M -0.04M -0.02M
Change to netincome - - 1.30M 1.35M 0.04M
Capital expenditures 0.00M 0.00M 0.05M 0.03M 0.03M
Change in working capital 0.01M -0.02M 0.05M -0.12M 0.30M
Stock based compensation 0.48M 1.68M 1.33M 1.34M 0.00M
Other non cash items 0.00M -0.00M -0.03M 0.01M 0.02M
Free cash flow -1.39M -3.23M -3.42M -2.51M -0.40M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
IRME
International Display Advertising Inc
-
-%
0.00 - - - 66.26 -6.76
ABT
Abbott Laboratories
-0.71
0.65%
108.58 25.97 17.24 3.57 3.20 16.75
MDT
Medtronic PLC
0.28
0.28%
101.89 26.60 15.87 3.35 2.08 14.12
SYK
Stryker Corporation
-2.16
0.68%
316.63 29.23 16.86 4.18 4.51 17.16
SEMHF
Siemens Healthineers AG
-
-%
47.31 39.57 21.32 3.01 3.29 16.92

Profile*

International Display Advertising Inc

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.

ZHR Industrial Zone, Rosh Pinna, Israel, 1231400

972 4 655 5054

3

Name Title Year Born
Mr. Oded Bashan Co-Founder & Chairman 1947
Mr. Aharon Klein Co-Founder, CTO & Director 1965
Mr. Aharon Binur Chief Devel. Officer 1964
Mr. Moshe Gerber Chief Exec. Officer 1961
Mr. Yaniv Cohen Co-Founder, R&D Researcher and Director 1980
Mr. Sharon Levkoviz Chief Financial Officer 1974
Mr. Yoram Drucker VP of Bus. Devel. & Director 1965
Mr. Avi Vachnis Head of Software & AI NA
Mr. Aharon Klein Co-Founder, CTO & Director 1962
Dr. Yaniv Cohen M.Sc., Ph.D. Co-Founder, Chief Scientific Officer & Director 1981

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…